TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo June 7, 2021 Keeren Shah Finance Director AccuStem Sciences Ltd 107 Cheapside, 9th Floor London EC2V 6DN United Kingdom Re: AccuStem Sciences Ltd Registration Statement on Form 20-F Filed March 12, 2021 File No. 000-56257 Dear Ms. Shah: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jeffrey Fessler, Esq.